Proto Labs Inc SEC 10-K Report
Proto Labs Inc. (PRLB) has released its 2025 10-K report, detailing significant financial growth, strategic operational changes, and challenges in a competitive market. The company achieved a 6.4% increase in total revenue to $533.1 million and a 28.0% rise in net income to $21.2 million, driven by strong performance in CNC Machining and Sheet Metal. Strategic initiatives include streamlining operations in Germany, continued international expansion, and capital management through share repurchases.
Inside Protolabs' new AI platform to accelerate product development
Protolabs has introduced ProDesk, an AI-enabled manufacturing platform designed to accelerate product development from prototyping to production. This new online environment provides real-time, AI-powered quoting with design for manufacturability analysis, enhanced collaboration tools, and a Production Catalog for managing and reordering parts. ProDesk aims to modernize the experience for product developers, engineers, and procurement teams by offering instant feedback, configurable quotes, and a centralized support hub.
3 Reasons to Avoid PRLB and 1 Stock to Buy Instead
Despite Proto Labs (PRLB) outperforming the S&P 500 significantly in the past six months, an analysis suggests investors should be cautious. The company exhibits disappointing long-term revenue growth, declining earnings per share, and negative returns on invested capital. StockStory advises avoiding PRLB due to its high valuation and recommends exploring other high-quality, market-beating stocks instead.
After Leaping 26% Proto Labs, Inc. (NYSE:PRLB) Shares Are Not Flying Under The Radar
Proto Labs, Inc. (NYSE:PRLB) shares have seen a significant 26% gain recently and a 53% increase over the last year, leading to a high P/E ratio of 75.3x compared to the market average. This elevated P/E is attributed to strong past and projected earnings growth, with analysts forecasting a 31% EPS increase for the next year, surpassing the market's 17% expectation. Investors appear willing to pay a premium for the stock due to these strong growth prospects.
Strategic Sale: Daniel Schumacher Decides To Exercise Options Worth $103K At Proto Labs
Daniel Schumacher, CFO at Proto Labs (NYSE: PRLB), exercised company stock options worth $103,204, involving 3,135 shares, as disclosed in an SEC filing on February 12. The article also provides a financial overview of Proto Labs, including its revenue growth, gross margin, EPS, debt management, and market valuation metrics. Insider transactions, while not the sole basis for investment decisions, offer valuable insights into a company's financial health and prospects.
Proto Labs and PayPal have been highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research has named Proto Labs (PRLB) as its Bull of the Day due to strong earnings momentum, especially given its role in digital manufacturing. Conversely, PayPal (PYPL) has been designated the Bear of the Day following a mixed Q4 report, reduced EPS estimates, and a "Sell" rating from Truist Securities. The article also touches on the recent underperformance of tech stocks, attributing it to rising CAPEX and uncertainties surrounding legacy software in the AI era.
Bull of the Day: Proto Labs (PRLB)
Proto Labs (PRLB) has been recognized as the "Bull of the Day" due to strong earnings momentum and its position in the digital manufacturing sector. Analysts have increased earnings estimates, forecasting significant growth for the current and next year. The company's focus on rapid prototyping and low-volume production, coupled with consistent earnings beats, makes it an attractive infrastructure play in modern manufacturing.
5 Insightful Analyst Questions From Proto Labs's Q4 Earnings Call
Proto Labs delivered strong Q4 2025 results, exceeding analyst expectations in revenue, EPS, and EBITDA, driven by growth in CNC machining and sheet metal. The CEO highlighted new operational initiatives and improved customer relationships as key factors. This article focuses on insightful questions posed by analysts during the earnings call, covering topics like demand patterns, customer strategy, defense sector involvement, injection molding growth, and demand visibility.
Essex Investment Management Co. LLC Invests $1.05 Million in Proto Labs, Inc. $PRLB
Essex Investment Management Co. LLC has invested $1.05 million in Proto Labs, Inc. by acquiring 20,886 shares, establishing a new position in the company. This move comes as Proto Labs surpassed Q4 earnings expectations with $0.44 EPS and $136.5M in revenue, and set strong Q1 2026 guidance. The stock is currently trading near its one-year high, reflecting a "Moderate Buy" consensus from analysts.
Proto Labs, Inc. (NYSE:PRLB) Given Consensus Rating of "Moderate Buy" by Brokerages
Proto Labs, Inc. (NYSE:PRLB) has received a consensus "Moderate Buy" rating from five brokerages, with an average 1-year price target of $53.33. This follows recent adjustments to analyst ratings, including a downgrade from "strong-buy" to "hold" by Zacks and an uplift in target price by Benchmark. The article also details recent insider selling activity and institutional trading, noting that institutions now own 84.54% of the company's stock.
Proto Labs (PRLB) Is Up 22.8% After Record 2025 Results and 2026 Transformation Pivot - What's Changed
Proto Labs (PRLB) reported record Q4 and full-year 2025 results, with significant revenue growth and a return to profitability. The company is embarking on a transformative 2026, focusing on strategic acquisitions and investments in high-growth services like CNC machining and medical capabilities. While the market has responded positively, the new acquisition strategy introduces integration and capital allocation risks alongside existing high valuation and the need for sustained multi-year earnings improvement.
Proto Labs (PRLB) Is Up 22.8% After Record 2025 Results and 2026 Transformation Pivot - What's Changed
Proto Labs (PRLB) recently reported record financial results for Q4 and full-year 2025, with revenue increases and a return to profitability. The company plans a transformative 2026, focusing on strategic acquisitions and investments in high-growth areas like CNC machining and medical services. This strategy aims to reshape its investment narrative, though it introduces integration risks alongside potential for growth.
Proto Labs (PRLB) Is Up 22.8% After Record 2025 Results and 2026 Transformation Pivot - What's Changed
Proto Labs (PRLB) recently reported record financial results for Q4 and full-year 2025, with increased revenue and profitability, leading to a 22.8% stock surge. The company plans a transformative 2026 focusing on high-growth services like CNC machining and medical capabilities, alongside selective acquisitions. While this strategy offers potential new catalysts, it also introduces integration and capital allocation risks amidst existing high expectations and valuation concerns.
AlphaQuest LLC Sells 18,130 Shares of Proto Labs, Inc. $PRLB
AlphaQuest LLC significantly reduced its stake in Proto Labs, Inc. by selling 18,130 shares, decreasing its holdings by 77.1%. Other institutional investors had mixed activity, with some increasing and others decreasing their positions. The article also covers Proto Labs' recent earnings beat, financial performance, analyst ratings, and an insider stock sale.
Kenison, Proto Labs COO, sells $150k in stock By Investing.com
Michael R. Kenison, Chief Operations Officer of Proto Labs Inc. (NASDAQ:PRLB), sold 2,500 shares of company stock for $150,000 on February 6, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. The sale followed a strong fourth-quarter earnings report where Proto Labs exceeded analyst expectations for both EPS and revenue.
Kenison, Proto Labs COO, sells $150k in stock
Michael R. Kenison, Chief Operations Officer of Proto Labs Inc. (NASDAQ:PRLB), sold 2,500 shares of company stock for $150,000 on February 6, 2026, as part of a pre-arranged trading plan. This insider transaction follows Proto Labs' strong fourth-quarter 2025 earnings report, where the company exceeded analyst expectations for both EPS and revenue.
Proto Labs (NYSE:PRLB) Insider Michael Kenison Sells 2,500 Shares
Proto Labs (NYSE:PRLB) insider Michael Kenison sold 2,500 shares of the company's stock on February 6th for a total of $150,000, reducing his stake by 6.75%. The sale followed a strong Q4 earnings report where the company beat analyst estimates with $0.44 EPS and $136.49M in revenue, and issued Q1 2026 guidance of $0.360–$0.440 EPS. Despite the insider sale, analysts maintain a "Moderate Buy" rating with an average target price of $53.33.
Proto Labs Earnings Call: Record Sales, Transformative 2026
Proto Labs Inc. reported record quarterly and annual revenue in its Q4 earnings call, with full-year 2025 revenue reaching $533.1 million. The company highlighted strong demand for CNC and sheet metal services, improved factory margins, and robust cash generation. Proto Labs is positioning 2026 as a "year of transformation," focusing on strategic investments despite challenges like European market weakness and a slowdown in prototyping activities for injection molding and 3D printing.
Proto Labs Earnings Call: Record Sales, Transformative 2026
Proto Labs Inc. reported record quarterly and annual revenue in its recent earnings call, driven by strong demand in CNC and sheet metal services and improved factory margins. The company highlighted its focus on deepening customer relationships and its robust cash generation but acknowledged weaknesses in European markets and some legacy services like injection molding and 3D printing. Looking ahead, Proto Labs plans a "year of transformation" in 2026, investing in strategic initiatives to support long-term growth and margin expansion despite facing short-term cost headwinds and a projected softer Q1.
Proto Labs Earnings Call: Record Sales, Transformative 2026
Proto Labs Inc. (PRLB) reported record quarterly and annual revenue in its latest earnings call, emphasizing strong demand in CNC and sheet metal, and robust cash generation. The company views 2026 as a "year of transformation," focusing on strategic investments and operational changes for long-term growth and margin expansion, despite short-term cost headwinds and weakness in the European market. While some legacy areas like injection molding and 3D printing faced challenges, Proto Labs is expanding into production work, particularly in regulated industries, aiming for $1 billion in revenue and higher margins in the long term.
Proto Labs, Inc. (NYSE:PRLB) Q4 2025 Earnings Call Transcript
Proto Labs, Inc. (NYSE:PRLB) announced strong Q4 and full-year 2025 financial results, with double-digit growth in Q4 revenue and exceeding EPS expectations. The company outlined a new long-term strategy focused on elevating customer experience, accelerating innovation, expanding production, and driving operational efficiency, aiming for sustained double-digit revenue growth and operating margin expansion, targeting $1 billion in annual revenue over time. Key initiatives for 2026 include a strategic reset in Europe and the establishment of a global capability center in India.
Proto Labs pivots injection molding toward production as plastics prototyping stays soft
Proto Labs Inc. is shifting its focus towards high-volume production in injection molding. This strategic pivot comes as the demand for plastics prototyping experiences a downturn. The company aims to increase its presence in the production sector to adapt to current market conditions.
Proto Labs shares surge after Q4 beat and stronger-than-expected outlook
Proto Labs (NYSE:PRLB) reported stronger-than-expected results for its fourth quarter, surpassing analysts' estimates for both earnings and revenue. The company also provided an optimistic outlook for the first quarter and the full fiscal year 2024, leading to a significant rally in its stock. This positive performance and guidance indicate a potential turnaround or robust growth trajectory for the on-demand manufacturing services provider.
Earnings call transcript: Proto Labs Q4 2025 earnings beat forecasts, stock surges
Proto Labs Inc. reported strong Q4 2025 earnings, with EPS of $0.44 and revenue of $136.5 million, both exceeding forecasts. This led to a 12.33% surge in pre-market stock trading. The company outlined a transformative strategy for 2026, focusing on customer experience, innovation, production expansion, and operational efficiency, aiming for sustained revenue growth and margin improvement.
Proto Labs (NYSE:PRLB) Reports Upbeat Q4 CY2025, Stock Jumps 14.7%
Proto Labs (NYSE:PRLB) reported strong Q4 CY2025 results, exceeding revenue and adjusted EPS expectations, which led to a 14.7% jump in its stock. The company provided upbeat guidance for Q1 CY2026 revenue and EPS, signaling continued positive momentum. Despite historical sluggish revenue growth, Q4 showed significant improvements in operating margin and accelerating EPS growth.
Proto Labs Inc (NYSE:PRLB) Posts Strong Q4 Beat, Outlines 2026 Strategic Shift
Proto Labs Inc (NYSE:PRLB) reported strong fourth-quarter 2025 financial results, beating analyst expectations for both revenue and EPS, driven by significant growth in its CNC Machining service. The company achieved record full-year revenue and outlined a strategic shift for 2026 focused on customer experience, innovation, production expansion, and operational efficiency. Investors reacted positively, with shares rising in pre-market trading, as Protolabs provided revenue growth guidance for 2026.
Proto Labs Expects Q1 Results To Improve; Stock Up Over 13% In Pre-Market
Proto Labs, Inc. (PRLB) has issued guidance for the first quarter of fiscal 2026, expecting net income between $0.17 and $0.25 per share and adjusted income from $0.36 to $0.44 per share on revenue of $130 million to $138 million. This represents an improvement over the first quarter of fiscal 2025. The company also projects a 6% to 8% revenue growth for the full fiscal year 2026, leading to a significant pre-market stock increase of over 13%.
Proto Labs: Q4 Earnings Snapshot
Proto Labs Inc. (PRLB) reported a net income of $6 million in its fourth quarter, translating to 25 cents per share and adjusted earnings of 44 cents per share. The custom parts manufacturer recorded revenues of $136.5 million for the quarter and $533.1 million for the full year. For the upcoming first fiscal quarter, Proto Labs anticipates earnings per share between 36 cents and 44 cents, with expected revenue ranging from $130 million to $138 million.
Protolabs Reports Financial Results for Q4 and Full Year 2025
Protolabs has announced strong financial results for Q4 and full year 2025, reporting record revenues and significant growth in segments like CNC Machining. The company achieved $136.5 million in revenue for Q4 and $533.1 million for the full year, with a positive net income. Protolabs plans to focus on strategic pillars like customer experience, innovation, and operational efficiency to drive further growth and expects revenue growth of 6% to 8% for fiscal year 2026.
Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2025
Protolabs (NYSE: PRLB) announced record financial results for the fourth quarter and full year ended December 31, 2025, with Q4 revenue reaching $136.5 million, a 12.1% increase year-over-year, and full-year revenue at $533.1 million, up 6.4%. The company detailed its strategic pillars for 2026, focusing on elevating customer experience, accelerating innovation, expanding production, and driving operational efficiency, and provided optimistic financial guidance for Q1 and the full fiscal year 2026.
What To Expect From Proto Labs's (PRLB) Q4 Earnings
Proto Labs (PRLB) is set to report its Q4 earnings on Friday, with analysts projecting a 6.3% year-on-year revenue growth to $129.5 million and adjusted earnings of $0.34 per share. The company has a strong record of beating revenue estimates, and sentiment in the industrial machinery segment has been positive despite Proto Labs' recent slight decline. Investors are looking to see if Proto Labs can maintain this positive trend.
Is The Market Rewarding Proto Labs, Inc. (NYSE:PRLB) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Proto Labs' stock is down 6.4%, prompting an examination of its fundamentals, particularly its low Return on Equity (ROE) of 2.2% compared to the industry average of 11%. This low ROE is correlated with a 19% decline in net income over five years. Despite the company retaining all profits due to not paying regular dividends, its inability to effectively grow the business through reinvestment raises questions about its future prospects, although analysts forecast future earnings growth.
Proto Labs (PRLB) to Release Quarterly Earnings on Friday
Proto Labs (PRLB) is set to announce its Q4 2025 earnings before market open on Friday, February 6th, with analysts forecasting $0.35 EPS and $129.07 million in revenue. The company previously surpassed estimates in Q3 2025, reporting $0.47 EPS and $135.37 million in revenue. Analysts project an average of $1.00 EPS for both the current and next fiscal years for Proto Labs.
Is The Market Rewarding Proto Labs, Inc. (NYSE:PRLB) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Proto Labs' stock has fallen 6.4% in the past week, prompting an examination of its fundamentals. The company's Return on Equity (ROE) is a weak 2.2%, significantly below the industry average of 11%, correlating with a 19% decline in net income over five years. Despite this, analysts expect future earnings growth, although the company's retention of profits without apparent business growth raises questions.
Proto Labs stock hits 52-week high at 55.96 USD By Investing.com
Proto Labs Inc. (PRLB) stock has hit a new 52-week high of $55.96, reflecting a 38.94% increase over the past year and a 42.46% gain in the last six months. The company, valued at $1.32 billion, has a strong balance sheet but an InvestingPro analysis suggests it might be trading above its Fair Value with a P/E ratio of nearly 90. Investors are anticipating Proto Labs' earnings report on February 6th, with analyst price targets ranging from $55 to $60, following a robust third-quarter 2025 performance that surpassed market expectations.
Proto Labs stock hits 52-week high at 55.96 USD
Proto Labs Inc. (PRLB) stock has reached a new 52-week high of $55.96, reflecting a significant 38.94% increase over the past year and 42.46% in the last six months. Despite a strong balance sheet and aggressive share buybacks, InvestingPro suggests the stock may be trading above its Fair Value with a P/E ratio of nearly 90. The company is set to report earnings on February 6th, with analysts forecasting price targets between $55-60.
Protolabs Sets Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
Protolabs (NYSE: PRLB) announced it will release its fourth quarter and full year 2025 financial results before the market opens on Friday, February 6, 2026. The company will host a conference call at 8:30 a.m. EST on the same day to discuss these results. A webcast of the call will be available on the Protolabs investor relations website.
Protolabs Sets Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
Protolabs (NYSE: PRLB) announced it will release its fourth quarter and full year 2025 financial results on Friday, February 6, 2026, before the market opens. The company will host a conference call and webcast on the same day at 8:30 a.m. EST to discuss these results. An audio replay will be available on the Protolabs investor relations website following the call.
Proto Labs, Inc. (NYSE:PRLB) Given Average Rating of "Moderate Buy" by Analysts
Proto Labs, Inc. (NYSE:PRLB) has received an average "Moderate Buy" rating from analysts, with a consensus 1-year price target of $53.33. The company recently exceeded its Q3 earnings and revenue estimates and provided Q4 guidance, despite trading at a high P/E ratio. Insider selling activity and significant institutional investor movements, including a large increase by JPMorgan, were also noted.
Protolabs to share 2025 earnings update in Feb. 6 investor call
Protolabs (NYSE: PRLB) announced it will release its fourth quarter and full year 2025 financial results on Friday, February 6, 2026, before the market opens. The company will host a conference call at 8:30 a.m. EST on the same day to discuss these results. A webcast of the call will be available on the Protolabs investor relations website.
Proto Labs (NYSE:PRLB) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?
Proto Labs (NYSE:PRLB) shares have crossed above their 200-day moving average, trading as high as $55.01, which is often seen as a bullish technical signal. Despite this, analyst opinions are mixed, with an average "Moderate Buy" rating and a target price of $53.33, alongside a recent downgrade from Zacks Research to "hold." The company reported strong Q3 earnings, beating EPS estimates, but a notable insider recently sold shares.
Pacer Advisors Inc. Has $411,000 Stock Holdings in Proto Labs, Inc. $PRLB
Pacer Advisors Inc. reduced its stake in Proto Labs, Inc. by 92.2% in the third quarter, retaining 8,216 shares valued at $411,000. Despite this, Proto Labs reported strong Q3 earnings, exceeding EPS and revenue estimates, and received a "Moderate Buy" consensus rating from analysts with an average target price of $53.33. Institutional investors currently own 84.54% of the stock, while an insider recently sold 3,048 shares.
Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Proto Labs (NYSE:PRLB) shows a concerning trend of declining Return on Capital Employed (ROCE) over the past five years, dropping from 10% to 3.3%. This decline, coupled with stagnant capital employed, suggests the company is becoming less efficient with its investments and may be a mature business with little recent growth. Consequently, the company's stock has seen a 69% depreciation over the same period, indicating market dissatisfaction with these trends.
Assenagon Asset Management S.A. Sells 38,090 Shares of Proto Labs, Inc. $PRLB
Assenagon Asset Management S.A. significantly reduced its stake in Proto Labs, Inc. (NYSE:PRLB) by selling 38,090 shares in Q3 2025, bringing its total ownership to 27,745 shares valued at $1.39 million. This sale comes amidst growing positive analyst sentiment, with increased price targets and a consensus "Moderate Buy" rating for Proto Labs. The company also reported strong Q3 earnings, beating analyst estimates, and provided positive guidance for Q4 2025.
Rice Hall James & Associates LLC Decreases Stock Holdings in Proto Labs, Inc. $PRLB
Rice Hall James & Associates LLC significantly reduced its stake in Proto Labs, Inc. (NYSE:PRLB) by 16.1% during the third quarter, while other institutional investors like Rubric Capital Management LP increased their holdings. Despite the reduction by Rice Hall James, analyst sentiment remains positive with a "Moderate Buy" rating and an average price target of $53.33, following a strong Q3 earnings beat and an upgrade to "strong-buy" by Zacks. Insider Michael R. Kenison also sold a portion of his shares, but institutional investors still own a substantial 84.54% of the company's stock.
Proto Labs, Inc. (NYSE:PRLB) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Proto Labs, Inc. (NYSE:PRLB) has received an average "Moderate Buy" rating from six brokerages, with an average 12-month price target of $53.33. This follows a recent earnings beat and an upgrade to "strong-buy" by Zacks Research, as well as a price target increase by Benchmark. Insider Michael R. Kenison recently trimmed his position by selling 3,048 shares.
Q3 Earnings Outperformers: Proto Labs (NYSE:PRLB) And The Rest Of The Industrial Machinery Stocks
This article analyzes the Q3 2025 earnings of industrial machinery stocks, highlighting Proto Labs (NYSE:PRLB) as a top performer. It discusses how innovation in automation and connected equipment drives demand in the sector, while also reviewing the performance of Icahn Enterprises (NASDAQ:IEP), Albany (NYSE:AIN), Kennametal (NYSE:KMT), and Mueller Water Products (NYSE:MWA). The report notes strong overall Q3 results for the sector with revenues beating estimates and provides an update on the broader market conditions.
Proto Labs (NYSE:PRLB) Shares Pass Above Two Hundred Day Moving Average - What's Next?
Proto Labs (NYSE:PRLB) recently saw its shares cross above their 200-day moving average, signaling potential short-term strength. This technical breakout is supported by positive analyst sentiment, with a consensus "Moderate Buy" rating and an average price target of $53.33. The company also reported strong Q3 results, beating revenue and EPS estimates, though its PE ratio remains high.
Proto Labs, Inc. (NYSE:PRLB) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Proto Labs, Inc. (NYSE:PRLB) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $53.33. The company recently surpassed earnings expectations, reporting Q3 EPS of $0.47 against a $0.39 estimate and revenue of $135.4 million, prompting several analysts to upgrade their ratings. Insider Michael Kenison recently sold 3,048 shares, while institutional investors hold approximately 84.5% of the stock.
Proto Labs, Inc. $PRLB Holdings Lowered by Intech Investment Management LLC
Intech Investment Management LLC reduced its stake in Proto Labs, Inc. (NYSE:PRLB) by 31.1% in the second quarter, bringing its total holdings to 11,175 shares. Despite this, other hedge funds increased their positions, and institutional investors collectively own 84.54% of the company's stock. Analysts currently rate PRLB as a "Moderate Buy" with an average price target of $53.33, following a quarter where the company beat EPS estimates and grew revenue by 8% year-over-year.
